Found: 84
Select item for more details and to access through your institution.
DNA vaccines against GPRC5D synergize with PD-1 blockade to treat multiple myeloma.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-00979-w
- By:
- Publication type:
- Article
EBV‐positive diffuse large B‐cell lymphoma, not otherwise specified: 2018 update on diagnosis, risk‐stratification and management.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 7, p. 953, doi. 10.1002/ajh.25112
- By:
- Publication type:
- Article
EBV-positive diffuse large B-cell lymphoma of the elderly: 2016 update on diagnosis, risk-stratification, and management.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 5, p. 529, doi. 10.1002/ajh.24370
- By:
- Publication type:
- Article
Recent advances in de novo CD5<sup>+</sup> diffuse large B cell lymphoma.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 9, p. 798, doi. 10.1002/ajh.23467
- By:
- Publication type:
- Article
Clinical and Immunological Effects of p53-Targeting Vaccines.
- Published in:
- Frontiers in Cell & Developmental Biology, 2024, p. 1, doi. 10.3389/fcell.2021.762796
- By:
- Publication type:
- Article
Clinical and Immunological Effects of p53-Targeting Vaccines.
- Published in:
- Frontiers in Cell & Developmental Biology, 2024, p. 1, doi. 10.3389/fcell.2021.762796
- By:
- Publication type:
- Article
EBV<sup>+</sup> high‐grade B cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements: a multi‐institutional study.
- Published in:
- Histopathology, 2022, v. 80, n. 3, p. 575, doi. 10.1111/his.14585
- By:
- Publication type:
- Article
Hepatitis B surface antigen positivity is associated with poor short- and long-term outcomes in patients with diffuse large B-cell lymphoma who received CHOP or R-CHOP.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1324113
- By:
- Publication type:
- Article
HBV-associated DLBCL of poor prognosis: advance in pathogenesis, immunity and therapy.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1216610
- By:
- Publication type:
- Article
Reprogrammed marrow adipocytes contribute to myeloma-induced bone disease.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 494, p. 1, doi. 10.1126/scitranslmed.aau9087
- By:
- Publication type:
- Article
Treatment-Related Adverse Events of Chimeric Antigen Receptor T-Cell (CAR T) in Clinical Trials: A Systematic Review and Meta-Analysis.
- Published in:
- Cancers, 2021, v. 13, n. 15, p. 3912, doi. 10.3390/cancers13153912
- By:
- Publication type:
- Article
hemaClass.org: Online One-By-One Microarray Normalization and Classification of Hematological Cancers for Precision Medicine.
- Published in:
- PLoS ONE, 2016, v. 11, n. 10, p. 1, doi. 10.1371/journal.pone.0163711
- By:
- Publication type:
- Article
Predictive Model for Idiopathic Multicentric Castleman Disease Supporting Treatment Decisions.
- Published in:
- Oncologist, 2021, v. 26, n. 1, p. 4, doi. 10.1002/onco.13605
- By:
- Publication type:
- Article
PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?
- Published in:
- Frontiers in Immunology, 2017, p. 1, doi. 10.3389/fimmu.2017.01597
- By:
- Publication type:
- Article
Tissue-specific microRNA expression alters cancer susceptibility conferred by a TP53 noncoding variant.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-13002-x
- By:
- Publication type:
- Article
Sequential Lymphomas or Clonally Unrelated Richter Syndrome of Chronic Lymphocytic Leukemia Into Mantle Cell Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 5, p. 606, doi. 10.1016/j.clml.2013.04.007
- By:
- Publication type:
- Article
Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: A report from the International DLBCL Rituximab-CHOP Consortium Program.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 12, p. 1818, doi. 10.1002/cncr.28664
- By:
- Publication type:
- Article
miR-301a as an NF-κB activator in pancreatic cancer cells.
- Published in:
- EMBO Journal, 2011, v. 30, n. 1, p. 57, doi. 10.1038/emboj.2010.296
- By:
- Publication type:
- Article
MicroRNAs associated to single drug components of R-CHOP identifies diffuse large B-cell lymphoma patients with poor outcome and adds prognostic value to the international prognostic index.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Prognostic factors, therapeutic approaches, and distinct immunobiologic features in patients with primary mediastinal large B-cell lymphoma on long-term follow-up.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 5, p. 1, doi. 10.1038/s41408-020-0312-7
- By:
- Publication type:
- Article
Correction: Mechanisms of ferroptosis and targeted therapeutic approaches in lymphoma.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Mechanisms of ferroptosis and targeted therapeutic approaches in lymphoma.
- Published in:
- Cell Death & Disease, 2023, v. 14, n. 11, p. 1, doi. 10.1038/s41419-023-06295-w
- By:
- Publication type:
- Article
Preclinical evaluation of a regimen combining chidamide and ABT-199 in acute myeloid leukemia.
- Published in:
- Cell Death & Disease, 2020, v. 11, n. 9, p. 1, doi. 10.1038/s41419-020-02972-2
- By:
- Publication type:
- Article
A statin-regulated microRNA represses human c-Myc expression and function.
- Published in:
- EMBO Molecular Medicine, 2012, v. 4, n. 9, p. 896, doi. 10.1002/emmm.201101045
- By:
- Publication type:
- Article
Posttranslational Modifications in PD-L1 Turnover and Function: From Cradle to Grave.
- Published in:
- Biomedicines, 2021, v. 9, n. 11, p. 1702, doi. 10.3390/biomedicines9111702
- By:
- Publication type:
- Article
Remodeling of anti-tumor immunity with antibodies targeting a p53 mutant.
- Published in:
- Journal of Hematology & Oncology, 2024, v. 17, n. 1, p. 1, doi. 10.1186/s13045-024-01566-1
- By:
- Publication type:
- Article
Revealing the evolution of the tumor immune microenvironment in follicular lymphoma patients progressing within 24 months using single-cell imaging mass cytometry.
- Published in:
- Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01326-z
- By:
- Publication type:
- Article
Hepatitis C virus positive diffuse large B-cell lymphomas have distinct molecular features and lack BCL2 translocations.
- Published in:
- British Journal of Cancer, 2017, v. 117, n. 11, p. 1685, doi. 10.1038/bjc.2017.345
- By:
- Publication type:
- Article
Hepatitis C virus positive diffuse large B-cell lymphomas have distinct molecular features and lack BCL2 translocations.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The Short-Term Efficacy and Safety of Brentuximab Vedotin Plus Cyclophosphamide, Epirubicin and Prednisone in Untreated PTCL: A Real-World, Retrospective Study.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 1, p. 532, doi. 10.1007/s12325-021-01943-z
- By:
- Publication type:
- Article
Natural killer/T-cell lymphoma-associated hemophagocytic syndrome: A case report.
- Published in:
- 2014
- By:
- Publication type:
- Case Study
Targeting PD-L1 in non-small cell lung cancer using CAR T cells.
- Published in:
- Oncogenesis, 2020, v. 9, n. 8, p. 1, doi. 10.1038/s41389-020-00257-z
- By:
- Publication type:
- Article
The third-generation anti-CD30 CAR T-cells specifically homing to the tumor and mediating powerful antitumor activity.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-14523-0
- By:
- Publication type:
- Article
Crystal-storing histiocytosis: a clinicopathological study of 13 cases.
- Published in:
- Histopathology, 2016, v. 68, n. 4, p. 482, doi. 10.1111/his.12768
- By:
- Publication type:
- Article
High-grade B cell lymphoma, unclassifiable, with blastoid features: an unusual morphological subgroup associated frequently with BCL2 and/or MYC gene rearrangements and a poor prognosis.
- Published in:
- Histopathology, 2012, v. 61, n. 5, p. 945, doi. 10.1111/j.1365-2559.2012.04301.x
- By:
- Publication type:
- Article
Identification of hepatitis B virus aetiologic antigens, HBx and Pre‐S2, in diffuse large B‐cell lymphoma.
- Published in:
- Journal of Viral Hepatitis, 2020, v. 27, n. 9, p. 948, doi. 10.1111/jvh.13301
- By:
- Publication type:
- Article
Expanding anti-CD38 immunotherapy for lymphoid malignancies.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02421-2
- By:
- Publication type:
- Article
CD19 CAR-T expressing PD-1/CD28 chimeric switch receptor as a salvage therapy for DLBCL patients treated with different CD19-directed CAR T-cell therapies.
- Published in:
- 2021
- By:
- Publication type:
- Letter
New agents and regimens for diffuse large B cell lymphoma.
- Published in:
- Journal of Hematology & Oncology, 2020, v. 13, n. 1, p. 1, doi. 10.1186/s13045-020-01011-z
- By:
- Publication type:
- Article
Ubiquitination of the DNA-damage checkpoint kinase CHK1 by TRAF4 is required for CHK1 activation.
- Published in:
- Journal of Hematology & Oncology, 2020, v. 13, n. 1, p. 1, doi. 10.1186/s13045-020-00869-3
- By:
- Publication type:
- Article
Richter transformation driven by Epstein–Barr virus reactivation during therapy‐related immunosuppression in chronic lymphocytic leukaemia.
- Published in:
- Journal of Pathology, 2018, v. 245, n. 1, p. 61, doi. 10.1002/path.5060
- By:
- Publication type:
- Article
Whole‐exome sequencing identifies novel somatic alterations associated with outcomes in idiopathic multicentric Castleman disease.
- Published in:
- British Journal of Haematology, 2020, v. 188, n. 5, p. e64, doi. 10.1111/bjh.16330
- By:
- Publication type:
- Article
The efficacy and safety of gemcitabine, cisplatin, prednisone, thalidomide versus CHOP in patients with newly diagnosed peripheral T-cell lymphoma with analysis of biomarkers.
- Published in:
- British Journal of Haematology, 2017, v. 178, n. 5, p. 772, doi. 10.1111/bjh.14763
- By:
- Publication type:
- Article
Evaluation of allelic strength of human TET2 mutations and cooperation between Tet2 knockdown and oncogenic Nras mutation.
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 3, p. 461, doi. 10.1111/bjh.12871
- By:
- Publication type:
- Article
Genome-wide high resolution DNA profiling of hairy cell leukaemia.
- Published in:
- British Journal of Haematology, 2013, v. 162, n. 4, p. 566, doi. 10.1111/bjh.12393
- By:
- Publication type:
- Article
A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome.
- Published in:
- British Journal of Haematology, 2011, v. 152, n. 3, p. 284, doi. 10.1111/j.1365-2141.2010.08482.x
- By:
- Publication type:
- Article
Intensive chemotherapy and sequential hematopoietic stem cell transplantation: Is it necessary for high‐risk T‐cell lymphoblastic lymphoma?
- Published in:
- Cancer Communications, 2021, v. 41, n. 3, p. 273, doi. 10.1002/cac2.12148
- By:
- Publication type:
- Article
The oncogenic microRNA miR-21 promotes regulated necrosis in mice.
- Published in:
- Nature Communications, 2015, v. 6, n. 5, p. 7151, doi. 10.1038/ncomms8151
- By:
- Publication type:
- Article
LIF negatively regulates tumour-suppressor p53 through Stat3/ID1/MDM2 in colorectal cancers.
- Published in:
- Nature Communications, 2014, v. 5, n. 10, p. 5218, doi. 10.1038/ncomms6218
- By:
- Publication type:
- Article
ETS1 phosphorylation at threonine 38 is associated with the cell of origin of diffuse large B cell lymphoma and sustains the growth of tumour cells.
- Published in:
- British Journal of Haematology, 2023, v. 203, n. 2, p. 244, doi. 10.1111/bjh.19018
- By:
- Publication type:
- Article